Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · May 30, 2022

Weight Regain and Cardiometabolic Effects After Withdrawal of Semaglutide

Diabetes, Obesity & Metabolism


Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes, Obesity & Metabolism
Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension
Diabetes Obes Metab 2022 Apr 19;[EPub Ahead of Print], JP Wilding, RL Batterham, M Davies, LFV Gaal, K Kandler, K Konakli, I Lingvay, BM McGowan, T Kalayci Oral, J Rosenstock, TA Wadden, S Wharton, K Yokote, RF Kushner

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading